未登录

S

Stefan Schwartz

uppsala university

H指数:40

被引数:4,981

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reporter assays for HPV16 E1/E1C and E2 mRNA splicing using nanoluciferase and secreted luciferase

利用纳米荧光素酶和分泌型荧光素酶对HPV16 E1/E1C和E2 mRNA剪接的报告基因分析

Journal of Virological Methods

IF1.6

2026-02-010

OAAI

hnRNP H controls alternative splicing of human papillomavirus type 16 E1, E6, E7, and E6∧E7 mRNAs via GGG motifs

JOURNAL OF VIROLOGY

IF3.8

2024-10-222

PRE

RNA elements that control human papillomavirus mRNA splicing-targets for therapy?

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2024-02-161

OAAI

A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization

NUCLEIC ACIDS RESEARCH

IF13.1

2023-11-225

OAAI

The role of RNA-binding proteins in the processing of mRNAs produced by carcinogenic papillomaviruses

SEMINARS IN CANCER BIOLOGY

IF15.7

2022-11-0116

OAAI

hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs

NUCLEIC ACIDS RESEARCH

IF13.1

2022-03-3113

OAAI

HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention

NUCLEIC ACIDS RESEARCH

IF13.1

2022-03-0213

OAAI

Role of Viral Ribonucleoproteins in Human Papillomavirus Type 16 Gene Expression

IF3.5

2020-09-3019

OAAI

Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region

JOURNAL OF VIROLOGY

IF3.8

2020-09-2927

OAAI

A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin

IF3.4

2019-03-2518

OAAI

Short half-life of HPV16 E6 and E7 mRNAs sensitizes HPV16-positive tonsillar cancer cell line HN26 to DNA-damaging drugs

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2018-11-0910

OAAI

The DNA damage response activates HPV16 late gene expression at the level of RNA processing

NUCLEIC ACIDS RESEARCH

IF13.1

2018-03-2722

OAAI

hnRNP G prevents inclusion on the HPV16 L1 mRNAs of the central exon between splice sites SA3358 and SD3632

JOURNAL OF GENERAL VIROLOGY

IF4.3

2018-03-0114

OA

hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner

NUCLEIC ACIDS RESEARCH

IF13.1

2017-07-1026

OAAI

Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3′-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2015-05-0129

OAAI

Suppression of HPV-16 late L1 5′-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs

NUCLEIC ACIDS RESEARCH

IF13.1

2013-09-0543

OAAI

Regulation of human papillomavirus gene expression by splicing and polyadenylation

NATURE REVIEWS MICROBIOLOGY

IF103.3

2013-03-11141

PREAI

HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation

IF8.3

2012-05-2267

OAAI

Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism

JOURNAL OF GENERAL VIROLOGY

IF4.3

2011-10-0134

OAAI

Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5′-Splice Site of Exon 3

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2010-10-0124

OAAI